Prion diseases: Epidemiology in man

被引:20
作者
Pedersen, NS [1 ]
Smith, E [1 ]
机构
[1] Statens Serum Inst, DK-2300 Copenhagen S, Denmark
关键词
Prion diseases in man; epidemiology; variant CJD; CJD; kuru;
D O I
10.1034/j.1600-0463.2002.100103.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Prion disease in man was first described as Creutzfeldt-Jacob disease (CJD) in the 19-20s, CJD may have three different origins: sporadic, familial, due to mutations in the prion gene, or infectious, due to iatrogenic exposure to infectious brain material. As an example of the latter, kuru, in Papua New Guinea, was a variant of CJD transmitted by cannibalism. Between 19577 and 19821 more than 2500 died of kuru. Sporadic CJD is the most common form of CJD and occurs with an incidence of around one. per million in most parts of the world. Familial CJD accounts for approximately 10% of all European cases of CJD, and is associated with inherited mutations of the prion protein gene, caused by one of the 24 single amino acid substitutions or insertions of octapeptide repeats. CJD caused by infections involves either iatrogenic cases of CJD, resulting from exposure to infectious brain, pituitary or ocular tissue, or from ingestion of infected food items. As of today, a few hundred iatrogenic cases of CJD have been diagnosed worldwide, the majority due to transmission pituitary HCG. So far, 111 cases of vCJD have been diagnosed caused by BSE-contaminated food. The size of the epidemic is still unclear and worst-case scenarios indicate that we may expect many thousands of cases in the future.
引用
收藏
页码:14 / 22
页数:9
相关论文
共 43 条
[1]   Incidence of variant Creutzfeldt-Jakob disease in the UK [J].
Andrews, NJ ;
Farrington, CP ;
Cousens, SN ;
Smith, PG ;
Ward, H ;
Knight, RSG ;
Ironside, JW ;
Will, RG .
LANCET, 2000, 356 (9228) :481-482
[2]  
BERNOULLI C, 1977, LANCET, V1, P478
[3]   HUMAN SPONGIFORM ENCEPHALOPATHY - THE NATIONAL-INSTITUTES-OF-HEALTH SERIES OF 300 CASES OF EXPERIMENTALLY TRANSMITTED DISEASE [J].
BROWN, P ;
GIBBS, CJ ;
RODGERSJOHNSON, P ;
ASHER, DM ;
SULIMA, MP ;
BACOTE, A ;
GOLDFARB, LG ;
GAJDUSEK, DC .
ANNALS OF NEUROLOGY, 1994, 35 (05) :513-529
[4]   Iatrogenic Creutzfeldt-Jakob disease at the millennium [J].
Brown, P ;
Preece, M ;
Brandel, JP ;
Sato, T ;
McShane, L ;
Zerr, I ;
Fletcher, A ;
Will, RG ;
Pocchiari, M ;
Cashman, NR ;
d'Aignaux, JH ;
Cervenáková, L ;
Fradkin, J ;
Schonberger, LB ;
Collins, SJ .
NEUROLOGY, 2000, 55 (08) :1075-1081
[5]   Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [J].
Bruce, ME ;
Will, RG ;
Ironside, JW ;
McConnell, I ;
Drummond, D ;
Suttie, A ;
McCardle, L ;
Chree, A ;
Hope, J ;
Birkett, C ;
Cousens, S ;
Fraser, H ;
Bostock, CJ .
NATURE, 1997, 389 (6650) :498-501
[6]   Phenotype-genotype studies in kuru:: Implications for new variant Creutzfeldt-Jakob disease [J].
Cervenáková, L ;
Goldfarb, LG ;
Garruto, R ;
Lee, HS ;
Gajdusek, DC ;
Brown, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) :13239-13241
[7]   CREUTZFELDT-JAKOB DISEASE IN A RECIPIENT OF HUMAN PITUITARY-DERIVED GONADOTROPIN [J].
COCHIUS, JI ;
BURNS, RJ ;
BLUMBERGS, PC ;
MACK, K ;
ALDERMAN, CP .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1990, 20 (04) :592-593
[8]   Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study [J].
Collins, S ;
Law, MG ;
Fletcher, A ;
Boyd, A ;
Kaldor, J ;
Masters, CL .
LANCET, 1999, 353 (9154) :693-697
[9]   Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000 [J].
Cousens, S ;
Smith, PG ;
Ward, H ;
Everington, D ;
Knight, RSG ;
Zeidler, M ;
Stewart, G ;
Smith-Bathgate, EAB ;
Macleod, MA ;
Mackenzie, J ;
Will, RG .
LANCET, 2001, 357 (9261) :1002-1007
[10]  
CREUTZFELDT HG, 1924, HISTOL HISTOPATH, V6, P1